Cardioprotective mechanisms of eplerenone on cardiac performance and remodeling in failing rat hearts

Hypertension
Naohiko KobayashiHiroaki Matsuoka

Abstract

Aldosterone may play a pivotal role in the pathophysiology of heart failure. To elucidate the beneficial cardioprotective mechanism of eplerenone, a novel selective aldosterone blocker, we hypothesized that eplerenone stimulates endothelial NO synthase (eNOS) through Akt and inhibits inducible NO synthase (iNOS) via nuclear factor kappaB (NF-kappaB) after the development of oxidative stress and activation of the lectin-like, oxidized, low-density lipoprotein receptor 1 (LOX-1) pathway in Dahl salt-sensitive rats with heart failure. Eplerenone (10, 30, and 100 mg/kg per day) was given from the age of the left ventricular hypertrophy stage (11 weeks) to the failing stage (18 weeks) for 7 weeks. The left ventricular end-systolic pressure-volume relationship was evaluated using a conductance catheter. Decreased percentage of fractional shortening by echocardiography and end-systolic pressure-volume relationship in failing rats was significantly ameliorated by eplerenone. Downregulated eNOS expression, eNOS and Akt phosphorylation, and NOS activity in failing rats were increased by eplerenone. Upregulated expression of the mineralocorticoid receptor aldosterone synthase (CYP11B2); NAD(P)H oxidase p22phox, p47phox, gp91phox, iNOS, an...Continue Reading

References

Feb 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J S BeckmanB A Freeman
Feb 13, 2001·The Journal of Clinical Investigation·T Collins, M I Cybulsky
Aug 16, 2001·Trends in Endocrinology and Metabolism : TEM·R Rocha, C T Stier
May 8, 2002·Circulation·Sanjay RajagopalanParesh Patel
Jun 8, 2002·Hypertension·Toshio NishikimiHiroaki Matsuoka
Aug 6, 2002·The Journal of Clinical Endocrinology and Metabolism·Michihiro YoshimuraHisao Ogawa
Aug 15, 2002·Cardiovascular Research·Naohiko KobayashiHiroaki Matsuoka
Nov 5, 2002·The American Journal of Pathology·Yao SunKarl T Weber
Feb 18, 2003·Current Opinion in Nephrology and Hypertension·Rhian M Touyz
Apr 2, 2003·The New England Journal of Medicine·Bertram PittUNKNOWN Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators
Apr 5, 2003·Kidney International·Eileen R BlasiEllen G McMahon
Feb 9, 2005·Hypertension·Glaucia E CalleraErnesto L Schiffrin

❮ Previous
Next ❯

Citations

Jun 23, 2012·The Journal of Membrane Biology·Benjamin F RemoGlenn I Fishman
Nov 20, 2008·Pflügers Archiv : European journal of physiology·Michael Gekle, Claudia Grossmann
Aug 3, 2010·Cardiovascular Drugs and Therapy·Felipe A Martinez
Dec 27, 2011·Cellular and Molecular Neurobiology·Kirtiman SrivastavaUlvi Bayraktutan
Mar 28, 2007·Current Heart Failure Reports·Min Zhang, Ajay M Shah
Apr 8, 2011·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Taishi NakamuraShokei Kim-Mitsuyama
Nov 12, 2009·Journal of Cardiovascular Pharmacology·Hiromichi FukushimaToshihiko Ishimitsu
Jan 14, 2012·Current Opinion in Nephrology and Hypertension·Aurelie Nguyen Dinh Cat, Frederic Jaisser
Jan 18, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Javad HabibiJames R Sowers
Jul 12, 2011·Physiological Reviews·Mark A SussmanMichael McGregor
Dec 30, 2011·American Journal of Nephrology·Adam T Whaley-ConnellJames R Sowers
Aug 11, 2010·The Journal of Clinical Investigation·Michael G UsherRichard M Mortensen
May 8, 2009·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Nadeem KhanNirmal Singh
Mar 2, 2010·Circulation Journal : Official Journal of the Japanese Circulation Society·Tomohide TakayaKoji Hasegawa
Nov 16, 2011·Circulation Journal : Official Journal of the Japanese Circulation Society·Wataru KoguchiToshihiko Ishimitsu
Jun 3, 2009·Current Heart Failure Reports·Marcelle D SmitDirk J van Veldhuisen
Dec 27, 2012·Clinical and Experimental Nephrology·Fumihiro SugiyamaToshihiko Ishimitsu
Dec 8, 2006·Expert Opinion on Pharmacotherapy·R M A Van de WalR T Gansevoort
Jun 17, 2016·Journal of Receptor and Signal Transduction Research·Carolina Morais AraujoMauro César Isoldi
Jun 25, 2009·Molecular and Cellular Endocrinology·C Grossmann, M Gekle
Mar 4, 2008·Cardiology Clinics·Bertram Pitt
Apr 11, 2008·The Journal of Steroid Biochemistry and Molecular Biology·Victoria CachofeiroVicente Lahera
Jul 15, 2006·Journal of Molecular and Cellular Cardiology·Peter F MountDavid A Power
Jun 16, 2015·International Journal of Endocrinology·Cristiana CatenaLeonardo A Sechi
Dec 1, 2010·Hormone Molecular Biology and Clinical Investigation·Victoria CachofeiroMaría Antonia Fortuño
Mar 23, 2010·Biochimica Et Biophysica Acta·Johannes FelsKristina Kusche-Vihrog
Oct 30, 2014·Frontiers in Endocrinology·Cristiana CatenaLeonardo A Sechi
Dec 10, 2014·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Milla Marques HermidorffMauro César Isoldi
Feb 18, 2015·Gastroenterology Research and Practice·Ning GeZhi Zeng
May 21, 2016·Journal of Hypertension·Ify MordiNikolaos Tzemos
Apr 26, 2008·American Journal of Hypertension·Naohiko KobayashiHiroaki Matsuoka
Jan 12, 2008·American Journal of Hypertension·Tomoyuki OhnoHiroaki Matsuoka
Nov 29, 2008·American Journal of Hypertension·Naohiko KobayashiHiroaki Matsuoka
May 1, 2010·American Journal of Hypertension·Naohiko KobayashiToshihiko Ishimitsu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.